Skip to main content
OpenTrials

Clinical trial condition

Unresectable Hepatocellular Carcinoma

Explore clinical trials studying Unresectable Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

57 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Unresectable Hepatocellular Carcinoma trial results

Completed

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

NCT01015833

Conditions
Adenocarcinoma, Advanced Adult Hepatocellular Carcinoma, Carcinoma, +18 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
  • Alaska Regional Hospital Anchorage, Alaska, United States
View all 673 locations
View Trial Details
Completed

A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

NCT04829383

Conditions
Unresectable Hepatocellular Carcinoma
Locations
  • University of Illinois Cancer Center Chicago, Illinois, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details

Related conditions